Category - Amgen

• ON THE AIR
• This week’s sPOrTs highlighTs
• Insurers keep aid meant to defray patient costs
• Insurers keep aid meant to defray patient costs
• Insurers keep aid meant to defray patient costs
• Copay assistance is meant to defray patient drug costs. Some insurers keep it instead
• AMGEN INC. DRUG TAVNEOS'S MAIN STUDY RETRACTED BY MEDICAL JOURNAL
• Amgen taps research firm to reassess Tavneos data
• Amgen taps research firm to reassess Tavneos data
• Amgen taps research firm to reassess Tavneos data
• Valley bio students mimic experiment­s done at Amgen
• Amgen to build new research facility
• Obesity drug tum trouble
• Amgen announces $900M expansion in New Albany
• Not-So-Bad Clinical Trial Results
• Not-So-Bad Clinical Trial Results
• An inside look at Amgen’s fall
• Firm reports success of weight loss drug
• Firm reports success of weight loss drug
• Amgen to test obesity drug for treating liver, kidney diseases
• Lung cancer drug secures approval
• Pharma giant Amgen opens manufactur­ing facility in Ohio
• Pharma giant Amgen opens manufactur­ing facility in Ohio